Eli Lilly & Co. (LLY) Social Stream
ELI LILLY & Co (LLY) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering LLY.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-27 | 12 | $315 | $183 | $272.666 | $286.37 | -4.79% |
| 2021-11-19 | 12 | $315 | $183 | $275.615 | $286.37 | -3.76% |
| 2021-12-08 | 12 | $315 | $183 | $278.615 | $286.37 | -2.71% |
| 2021-12-15 | 13 | $315 | $250 | $285.307 | $286.37 | -0.37% |
| 2021-12-16 | 13 | $335 | $250 | $290.615 | $286.37 | 1.48% |
| 2021-12-20 | 13 | $335 | $265 | $299.076 | $286.37 | 4.44% |
| 2022-01-12 | 13 | $335 | $265 | $299.846 | $286.37 | 4.71% |
| 2022-02-04 | 12 | $335 | $265 | $299.846 | $286.37 | 4.71% |
| 2022-02-14 | 12 | $335 | $265 | $299.307 | $286.37 | 4.52% |
| 2022-02-24 | 12 | $335 | $265 | $298.615 | $286.37 | 4.28% |
| 2022-03-10 | 12 | $335 | $265 | $297.714 | $286.37 | 3.96% |
| 2022-03-17 | 12 | $335 | $265 | $298.785 | $286.37 | 4.34% |
The Trend in the Analyst Price Target
Over the past 23 months, LLY's average price target has gone up $138.21.
Over the past 50 weeks, LLY's average upside potential has been 9.48%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-05-15 | 21 | 252 | 175 | 213.410 | 196.21 | 8.77% |
| 2021-09-11 | 23 | 315 | 193 | 262.240 | 239.50 | 9.49% |
| 2021-09-20 | 22 | 315 | 202 | 265.880 | 231.64 | 14.78% |
| 2021-11-23 | 12 | 315 | 183 | 278.615 | 261.96 | 6.36% |
| 2022-02-04 | 12 | 335 | 265 | 299.846 | 242.27 | 23.77% |
LLY Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.17 | 11 | 0 | 1 | 0 | 0 | 12 |
The Trend in the Broker Recommendations
Over the past 23 months, LLY's average broker recommendation rating improved by 0.83.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for LLY as an investment opportunity.
- LLY has a higher average analyst price target than 1218.55% of all US stocks.
- In terms of how ELI LILLY & Co fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is greater than 39.89% of that group.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, ELI LILLY & Co's number of analysts covering the stock is greater than 1129.31% of them.
- In the context of stocks in the mega market cap category, ELI LILLY & Co's variance in analysts' estimates is lower than -289.84% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to ELI LILLY & Co are JNJ, ABT, and ABBV.
Is LLY a Buy, Hold or Sell? See the POWR Ratings now!